SCHEMBL3301465

SCHEMBL3301465

CCCOc1cc([N+](=O)[O-])ccc1NS(C)(=O)=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 20/20 1.00
KDM4E B2RXH2 1/20 0.62
MEN1 O00255 1/20 0.62
MLNR O43193 1/20 0.62
LMNA P02545 1/20 0.62
MMP1 P03956 1/20 0.62
MPO P05164 1/20 0.62
CYP1A2 P05177 1/20 0.62
GLA P06280 1/20 0.62
CYP3A4 P08684 1/20 0.62
ADORA3 P0DMS8 1/20 0.62
MAPT P10636 1/20 0.62
CYP2C9 P11712 1/20 0.62
HPGD P15428 1/20 0.62
TSHR P16473 1/20 0.62
TBXA2R P21731 1/20 0.62
PTGS1 P23219 1/20 0.62
SLC6A2 P23975 1/20 0.62
APEX1 P27695 1/20 0.62
HTR2C P28335 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3295100 0.91 CYP19A1 (1.00) CYP19A1
SCHEMBL3294121 0.91 CYP19A1 (1.00) CYP19A1
SCHEMBL3295927 0.84 CYP19A1 (1.00) CYP19A1KDM4EMEN1MLNRLMNA
SCHEMBL3299674 0.83 CYP19A1 (1.00) CYP19A1
SCHEMBL3247619 0.82 CYP19A1 (0.72) CYP19A1KDM4EMEN1MLNRLMNA
SCHEMBL14799084 0.81 CYP19A1 (0.89) CYP19A1MEN1CYP1A2CYP3A4MAPT
SCHEMBL3295792 0.81 CYP19A1 (1.00) CYP19A1KDM4EMEN1MLNRLMNA
SCHEMBL3300079 0.80 CYP19A1 (1.00) CYP19A1
SCHEMBL3299098 0.79 CYP19A1 (1.00) CYP19A1
SCHEMBL3295697 0.79 CYP19A1 (1.00) CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741520-B2 Sulfonanilide analogs as selective aromatase modulators (SAMs) THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-06-22 US disclosed
EP-1984325-A2 SULFONANILIDE ANALOGS AS SELECTIVE AROMATASE MODULATORS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2008-10-29 EP disclosed
US-20080045598-A1 Novel sulfonanilide analogs as selective aromatase modulators (SAMs) THE OHIO STATE UNIVERSITY (US) 2008-02-21 US disclosed
WO-2007120379-A2 SULFONANILIDE ANALOGS AS SELECTIVE AROMATASE MODULATORS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045598-A1 Novel sulfonanilide analogs as selective aromatase modulators (SAMs) CYP19A1, AR, SULT2A1 CYP19A1 1/4885KDM4E 530/4885MEN1 3204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.